The impact of remdesivir on SARS-CoV-2 evolution in vivo is a research paper published in JCI Insight (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Quantitative Biosciences Institute Coronavirus Research Group (QCRG) Antiviral Drug Discovery (AViDD) center
Grant: NIH U19AI171110
COVID-19 Supplemental Research awards from the National Institutes of Health’s (NIH’s) National Center for Advancing Translational Sciences
Grant: UL1 TR002389,UL1 TR001422
Northwestern University Cancer Center
Grant: P30 CA060553
NIH-supported Third Coast CFAR
Grant: P30 AI117943
NIH grant R21
Grant: AI163912
NIH grant U19
Grant: AI135964
Dixon Translational Research Grant
Grant: XXXXXXXX
NIH grant S10
Grant: S10OD032243
NIAID NIH HHS
Grant: T32 AI007476
NCATS NIH HHS
Grant: UL1 TR001422
NIAID NIH HHS
Grant: U19 AI171110
NIAID NIH HHS
Grant: R01 AI177498
NIAID NIH HHS
Grant: R21 AI163912
NIAID NIH HHS
Grant: U19 AI135964
NCATS NIH HHS
Grant: UL1 TR002389
FWCI
4.50
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords